The India Gastrointestinal Products Market was valued at $207.2 Million in 2024 and projected to reach to $308 Million by 2029, representing a compound annual growth rate of 8.2%. India's gastrointestinal products market is poised for sustained expansion through 2029, driven by demographic shifts, rising disposable incomes, and increased healthcare accessibility across tier-2 and tier-3 cities.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
India's gastrointestinal products market is valued at USD 207.2 million in 2024, with a projected expansion to USD 308.0 million by 2029, representing a robust 8.2% CAGR that outpaces the global average of 6.1%.
Increasing government healthcare spending and private sector investments in India are driving accessibility to gastrointestinal treatments, particularly in urban and semi-urban regions across the country.
India faces escalating rates of digestive disorders including IBS, GERD, and inflammatory bowel diseases, driven by changing dietary patterns, urbanization, and lifestyle factors among the growing middle class.
Enhanced health consciousness and digital health literacy among Indian consumers are driving demand for preventive gastrointestinal products, supplements, and over-the-counter medications.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | IRRITABLE BOWEL SYNDROME (IBS) (Disease) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 6.1% from 2024 to 2029 |
| Largest Segment | ENDOSCOPY DEVICES (Device) |
| Market Size Base Year (Billions) | ~USD 14.65 (2024) |
| Revenue Forecast (Billions) | ~USD 19.7 (2029) |
| Segments Covered | Device, Type, Disease, End User |
4 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY SURGICAL CENTERS & INDEPENDENT DIAGNOSTIC CENTERS | 113.5 | 120.7 | 128.8 | 137.6 | 147 | 157.2 | 168.1 | 200 | 9.2 |
| CLINICS | 49.1 | 51.1 | 53.5 | 56 | 58.7 | 61.5 | 64.5 | 75.2 | 7.1 |
| HOSPITALS | 161.3 | 173.1 | 186.5 | 201.2 | 217.1 | 234.4 | 253.1 | 238.8 | 5.1 |
| OTHER END USERS | 45.4 | 47.5 | 49.8 | 52.3 | 55 | 57.8 | 60.8 | 71.1 | 7.4 |
| TOTAL | 369.3 | 392.4 | 418.6 | 447.2 | 477.9 | 511 | 546.5 | 585.1 | 6.9 |
India's gastrointestinal products market was valued at USD 207.2 million in 2024 and is projected to grow to USD 308.0 million by 2029.
India's gastrointestinal products market is expected to grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.
Key growth drivers in India include rising healthcare expenditure, increasing prevalence of digestive disorders, growing consumer awareness, improved healthcare infrastructure, and rising disposable incomes in urban and semi-urban regions.
India's market growth rate of 8.2% CAGR significantly outpaces the global average of 6.1%, indicating stronger domestic demand and market expansion potential.
India's gastrointestinal products market includes pharmaceuticals, dietary supplements, and medical devices targeting conditions such as acid reflux, irritable bowel syndrome, and inflammatory bowel disease.
The study involved four major activities to estimate the current size of the gastroenterology products market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Gastrointestinal Products Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Extensive primary research was conducted after obtaining information regarding the Gastroenterology Products Market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the gastrointestinal products market.; and key opinion leaders.
Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market. the following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure
The research methodology used to estimate the size of the gastrointestinal products market includes the following details. The market sizing of the market was undertaken from the global side.
The size of the gastrointestinal products market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall gastrointestinal products market was obtained from secondary data and validated by primary participants to arrive at the total gastroenterology products market. Primary participants further validated the numbers.
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Gastroenterology/Gastrointestinal Products Market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.


To know about the assumptions considered for the study, Request for Free Sample Report
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the gastrointestinal products market.
Gastroenterology products encompass a variety of medical devices, diagnostic tools, and pharmaceuticals designed to diagnose, treat, and manage diseases and disorders of the gastrointestinal tract. These products include endoscopes, capsule endoscopy systems, ablation devices, stents, and specialized medications aimed at conditions like GERD, IBD, and colorectal cancer. Their purpose is to improve patient outcomes by offering advanced solutions for both diagnostic and therapeutic procedures within the GI tract.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Gastrointestinal Products Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report